Comprehensive Income (Loss), Net of Tax, Attributable to Parent of T2 Biosystems, Inc. from 31 Dec 2012 to 31 Mar 2024

Taxonomy & unit: us-gaap: USD
Description: Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.
Summary: T2 Biosystems, Inc. quarterly and annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent in USD history and change rate from 31 Dec 2012 to 31 Mar 2024.
T2 Biosystems, Inc. Comprehensive Income (Loss), Net of Tax, Attributable to Parent for the quarter ending 31 Mar 2024 was $13,534,000, a 25% increase year-over-year.
T2 Biosystems, Inc. Comprehensive Income (Loss), Net of Tax, Attributable to Parent for the twelve months ending 31 Mar 2024 was $45,646,000, a 28% increase year-over-year.
T2 Biosystems, Inc. annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent for 2023 was $50,077,000, a 19% increase from 2022.
T2 Biosystems, Inc. annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent for 2022 was $61,999,000, a 26% decline from 2021.
T2 Biosystems, Inc. annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent for 2021 was $49,254,000, a 5.3% decline from 2020.
Source SEC data: View on sec.gov

Comprehensive Income (Loss), Net of Tax, Attributable to Parent, Trailing 12 Months (USD)

Comprehensive Income (Loss), Net of Tax, Attributable to Parent, Quarterly (USD)

Comprehensive Income (Loss), Net of Tax, Attributable to Parent, YoY Quarterly Change (%)

Comprehensive Income (Loss), Net of Tax, Attributable to Parent, Annual (USD)

Comprehensive Income (Loss), Net of Tax, Attributable to Parent, YoY Annual Change (%)

T2 Biosystems, Inc. Quarterly Comprehensive Income (Loss), Net of Tax, Attributable to Parent (USD)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
Q1 2024	$45,646,000	$13,534,000	+$4,431,000	+25%	01 Jan 2024	31 Mar 2024	10-Q	06 May 2024	2024	Q1
Q4 2023	$50,077,000	$10,340,000	-$241,000	-2.4%	01 Oct 2023	31 Dec 2023	10-K	01 Apr 2024	2023	FY
Q3 2023	$49,836,000	$15,425,000	+$1,950,000	+11%	01 Jul 2023	30 Sep 2023	10-Q	15 Nov 2023	2023	Q3
Q2 2023	$51,786,000	$6,347,000	+$11,676,000	+65%	01 Apr 2023	30 Jun 2023	10-Q	08 Aug 2023	2023	Q2
Q1 2023	$63,462,000	$17,965,000	-$1,463,000	-8.9%	01 Jan 2023	31 Mar 2023	10-Q	06 May 2024	2024	Q1
Q4 2022	$61,999,000	$10,099,000	+$2,053,000	+17%	01 Oct 2022	31 Dec 2022	10-K	01 Apr 2024	2023	FY
Q3 2022	$64,052,000	$17,375,000	-$3,413,000	-24%	01 Jul 2022	30 Sep 2022	10-Q	15 Nov 2023	2023	Q3
Q2 2022	$60,639,000	$18,023,000	-$5,536,000	-44%	01 Apr 2022	30 Jun 2022	10-Q	08 Aug 2023	2023	Q2
Q1 2022	$55,103,000	$16,502,000	-$5,849,000	-55%	01 Jan 2022	31 Mar 2022	10-Q	12 May 2022	2022	Q1
Q4 2021	$49,254,000	$12,152,000	-$2,288,000	-23%	01 Oct 2021	31 Dec 2021	10-K	31 Mar 2023	2022	FY
Q3 2021	$46,966,000	$13,962,000	-$2,671,000	-24%	01 Jul 2021	30 Sep 2021	10-Q	04 Nov 2021	2021	Q3
Q2 2021	$44,295,000	$12,487,000	-$1,802,000	-17%	01 Apr 2021	30 Jun 2021	10-Q	16 Aug 2022	2022	Q2
Q1 2021	$42,493,000	$10,653,000	+$4,296,000	+29%	01 Jan 2021	31 Mar 2021	10-Q	12 May 2022	2022	Q1
Q4 2020	$46,789,000	$9,864,000			01 Oct 2020	31 Dec 2020	10-K	23 Mar 2022	2021	FY
Q3 2020		$11,291,000	+$2,880,000	+20%	01 Jul 2020	30 Sep 2020	10-Q	04 Nov 2021	2021	Q3
Q2 2020		$10,685,000			01 Apr 2020	30 Jun 2020	10-Q	09 Aug 2021	2021	Q2
Q1 2020		$14,949,000			01 Jan 2020	31 Mar 2020	10-Q	13 May 2021	2021	Q1
Q3 2019		$14,171,000			01 Jul 2019	30 Sep 2019	10-Q	05 Nov 2020	2020	Q3
Q3 2016		$12,783,000	-$1,139,000	-9.8%	01 Jul 2016	30 Sep 2016	10-Q	08 Nov 2016	2016	Q3
Q4 2015	$45,290,000	$12,032,000	-$2,956,000	-33%	01 Oct 2015	31 Dec 2015	10-K	15 Mar 2017	2016	FY
Q3 2015	$42,334,000	$11,644,000	-$3,553,000	-44%	01 Jul 2015	30 Sep 2015	10-Q	08 Nov 2016	2016	Q3
Q2 2015	$38,781,000	$10,995,000	-$3,692,000	-51%	01 Apr 2015	30 Jun 2015	10-Q	05 Aug 2015	2015	Q2
Q1 2015	$35,089,000	$10,619,000	-$3,699,000	-53%	01 Jan 2015	31 Mar 2015	10-Q	06 May 2015	2015	Q1
Q4 2014	$31,390,000	$9,076,000			01 Oct 2014	31 Dec 2014	10-K	15 Mar 2017	2016	FY
Q3 2014		$8,091,000	-$3,449,000	-74%	01 Jul 2014	30 Sep 2014	10-Q	04 Nov 2015	2015	Q3
Q2 2014		$7,303,000	-$2,289,000	-46%	01 Apr 2014	30 Jun 2014	10-Q	05 Aug 2015	2015	Q2
Q1 2014		$6,920,000			01 Jan 2014	31 Mar 2014	10-Q	06 May 2015	2015	Q1
Q3 2013		$4,642,000			01 Jul 2013	30 Sep 2013	10-Q	05 Nov 2014	2014	Q3
Q2 2013		$5,014,000			01 Apr 2013	30 Jun 2013	10-Q	19 Sep 2014	2014	Q2

T2 Biosystems, Inc. Annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent (USD)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
2023	$50,077,000	+$11,922,000	+19%	01 Jan 2023	31 Dec 2023	10-K	01 Apr 2024	2023	FY
2022	$61,999,000	-$12,745,000	-26%	01 Jan 2022	31 Dec 2022	10-K	01 Apr 2024	2023	FY
2021	$49,254,000	-$2,465,000	-5.3%	01 Jan 2021	31 Dec 2021	10-K	31 Mar 2023	2022	FY
2020	$46,789,000	+$12,217,000	+21%	01 Jan 2020	31 Dec 2020	10-K	23 Mar 2022	2021	FY
2019	$59,006,000			01 Jan 2019	31 Dec 2019	10-K	31 Mar 2021	2020	FY
2016	$54,804,000	-$9,514,000	-21%	01 Jan 2016	31 Dec 2016	10-K	15 Mar 2017	2016	FY
2015	$45,290,000	-$13,900,000	-44%	01 Jan 2015	31 Dec 2015	10-K	15 Mar 2017	2016	FY
2014	$31,390,000	-$10,780,000	-52%	01 Jan 2014	31 Dec 2014	10-K	15 Mar 2017	2016	FY
2013	$20,610,000	-$6,155,000	-43%	01 Jan 2013	31 Dec 2013	10-K	04 Mar 2015	2014	FY
2012	$14,455,000			01 Jan 2012	31 Dec 2012	10-K	04 Mar 2015	2014	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.